Literature DB >> 27194758

CD47 Plays a Role as a Negative Regulator in Inducing Protective Immune Responses to Vaccination against Influenza Virus.

Young-Tae Lee1, Eun-Ju Ko1,2, Youri Lee2, Yu-Na Lee1, Zhen Bian2, Yuan Liu2, Sang-Moo Kang3,2.   

Abstract

UNLABELLED: An integrin-associated protein CD47, which is a ligand for the inhibitory receptor signal regulatory protein α, is expressed on B and T cells, as well as on most innate immune cells. However, the roles of CD47 in the immune responses to viral infection or vaccination remain unknown. We investigated the role of CD47 in inducing humoral immune responses after intranasal infection with virus or immunization with influenza virus-like particles (VLPs). Virus infection or vaccination with VLPs containing hemagglutinin from A/PR8/34 influenza virus induced higher levels of antigen-specific IgG2c isotype dominant antibodies in CD47-deficient (CD47KO) mice than in wild-type (WT) mice. CD47KO mice with vaccination showed greater protective efficacy against lethal challenge, as evidenced by no loss in body weight and reduced lung viral titers compared to WT mice. In addition, inflammatory responses which include cytokine production, leukocyte infiltrates, and gamma interferon-producing CD4(+) T cells, as well as an anti-inflammatory cytokine (interleukin-10), were reduced in the lungs of vaccinated CD47KO mice after challenge with influenza virus. Analysis of lymphocytes indicated that GL7(+) germinal center B cells were induced at higher levels in the draining lymph nodes of CD47KO mice compared to those in WT mice. Notably, CD47KO mice exhibited significant increases in the numbers of antigen-specific memory B cells in spleens and plasma cells in bone marrow despite their lower levels of background IgG antibodies. These results suggest that CD47 plays a role as a negative regulator in inducing protective immune responses to influenza vaccination. IMPORTANCE: Molecular mechanisms that control B cell activation to produce protective antibodies upon viral vaccination remain poorly understood. The CD47 molecule is known to be a ligand for the inhibitory receptor signal regulatory protein α and expressed on the surfaces of most immune cell types. CD47 was previously demonstrated to play an important role in modulating the migration of monocytes, neutrophils, polymorphonuclear neutrophils, and dendritic cells into the inflamed tissues. The results of this study demonstrate new roles of CD47 in negatively regulating the induction of protective IgG antibodies, germinal center B cells, and plasma cells secreting antigen-specific antibodies, as well as macrophages, upon influenza vaccination and challenge. As a consequence, vaccinated CD47-deficient mice demonstrated better control of influenza viral infection and enhanced protection. This study provides insights into understanding the regulatory functions of CD47 in inducing adaptive immunity to vaccination.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27194758      PMCID: PMC4944296          DOI: 10.1128/JVI.00605-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection.

Authors:  Kevin L Legge; Thomas J Braciale
Journal:  Immunity       Date:  2003-02       Impact factor: 31.745

2.  Signal regulatory protein α regulates the homeostasis of T lymphocytes in the spleen.

Authors:  Miho Sato-Hashimoto; Yasuyuki Saito; Hiroshi Ohnishi; Hiroko Iwamura; Yoshitake Kanazawa; Tetsuya Kaneko; Shinya Kusakari; Takenori Kotani; Munemasa Mori; Yoji Murata; Hideki Okazawa; Carl F Ware; Per-Arne Oldenborg; Yoshihisa Nojima; Takashi Matozaki
Journal:  J Immunol       Date:  2011-06-01       Impact factor: 5.422

3.  In vivo, dendritic cells can cross-present virus-like particles using an endosome-to-cytosol pathway.

Authors:  Víctor Gabriel Morón; Paloma Rueda; Christine Sedlik; Claude Leclerc
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

4.  Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses.

Authors:  L Buonaguro; M L Tornesello; M Tagliamonte; R C Gallo; L X Wang; R Kamin-Lewis; S Abdelwahab; G K Lewis; F M Buonaguro
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 5.  Integrin-associated protein (CD47) and its ligands.

Authors:  E J Brown; W A Frazier
Journal:  Trends Cell Biol       Date:  2001-03       Impact factor: 20.808

6.  Targeting SIRP-α protects from type 2-driven allergic airway inflammation.

Authors:  Marianne Raymond; Vu Quang Van; Manuel Rubio; Karl Welzenbach; Marika Sarfati
Journal:  Eur J Immunol       Date:  2010-12       Impact factor: 5.532

7.  Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production.

Authors:  C M Snapper; W E Paul
Journal:  Science       Date:  1987-05-22       Impact factor: 47.728

Review 8.  Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway.

Authors:  Takashi Matozaki; Yoji Murata; Hideki Okazawa; Hiroshi Ohnishi
Journal:  Trends Cell Biol       Date:  2009-01-12       Impact factor: 20.808

Review 9.  The germinal center response.

Authors:  Kristy L Wolniak; Stephen M Shinall; Thomas J Waldschmidt
Journal:  Crit Rev Immunol       Date:  2004       Impact factor: 2.214

10.  Selective control of SIRP-alpha-positive airway dendritic cell trafficking through CD47 is critical for the development of T(H)2-mediated allergic inflammation.

Authors:  Marianne Raymond; Manuel Rubio; Geneviève Fortin; Karim Hamdy Shalaby; Hamida Hammad; Bart N Lambrecht; Marika Sarfati
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

View more
  10 in total

Review 1.  I'm Infected, Eat Me! Innate Immunity Mediated by Live, Infected Cells Signaling To Be Phagocytosed.

Authors:  Tim Birkle; G C Brown
Journal:  Infect Immun       Date:  2021-04-16       Impact factor: 3.441

2.  Low-dose cadmium potentiates lung inflammatory response to 2009 pandemic H1N1 influenza virus in mice.

Authors:  Joshua D Chandler; Xin Hu; Eun-Ju Ko; Soojin Park; Jolyn Fernandes; Young-Tae Lee; Michael L Orr; Li Hao; M Ryan Smith; David C Neujahr; Karan Uppal; Sang-Moo Kang; Dean P Jones; Young-Mi Go
Journal:  Environ Int       Date:  2019-04-15       Impact factor: 9.621

Review 3.  New Targets for Antiviral Therapy: Inhibitory Receptors and Immune Checkpoints on Myeloid Cells.

Authors:  Yanni Liu; Paul Nicklin; Yuan He
Journal:  Viruses       Date:  2022-05-25       Impact factor: 5.818

4.  Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses.

Authors:  Young-Tae Lee; Eun-Ju Ko; Youri Lee; Ki-Hye Kim; Min-Chul Kim; Yu-Na Lee; Sang-Moo Kang
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

5.  Dual-linker gold nanoparticles as adjuvanting carriers for multivalent display of recombinant influenza hemagglutinin trimers and flagellin improve the immunological responses in vivo and in vitro.

Authors:  Chao Wang; Wandi Zhu; Bao-Zhong Wang
Journal:  Int J Nanomedicine       Date:  2017-07-04

6.  Upregulation of CD47 Is a Host Checkpoint Response to Pathogen Recognition.

Authors:  Michal Caspi Tal; Laughing Bear Torrez Dulgeroff; Lara Myers; Irving L Weissman; Kim J Hasenkrug; Lamin B Cham; Katrin D Mayer-Barber; Andrea C Bohrer; Ehydel Castro; Ying Ying Yiu; Cesar Lopez Angel; Ed Pham; Aaron B Carmody; Ronald J Messer; Eric Gars; Jens Kortmann; Maxim Markovic; Michaela Hasenkrug; Karin E Peterson; Clayton W Winkler; Tyson A Woods; Paige Hansen; Sarah Galloway; Dhananjay Wagh; Benjamin J Fram; Thai Nguyen; Daniel Corey; Raja Sab Kalluru; Niaz Banaei; Jayakumar Rajadas; Denise M Monack; Aijaz Ahmed; Debashis Sahoo; Mark M Davis; Jeffrey S Glenn; Tom Adomati; Karl S Lang
Journal:  mBio       Date:  2020-06-23       Impact factor: 7.867

Review 7.  CD47 as a promising therapeutic target in oncology.

Authors:  Hai Zhao; Shuangshuang Song; Junwei Ma; Zhiyong Yan; Hongwei Xie; Ying Feng; Shusheng Che
Journal:  Front Immunol       Date:  2022-08-22       Impact factor: 8.786

8.  Loss of CD47 alters CD8+ T cell activation in vitro and immunodynamics in mice.

Authors:  Pulak R Nath; Dipasmita Pal-Nath; Sukhbir Kaur; Arunkumar Gangaplara; Thomas J Meyer; Margaret C Cam; David D Roberts
Journal:  Oncoimmunology       Date:  2022-09-06       Impact factor: 7.723

9.  CD47 Potentiates Inflammatory Response in Systemic Lupus Erythematosus.

Authors:  Jin Kyun Park; Ye Ji Lee; Ji Soo Park; Eun Bong Lee; Yeong Wook Song
Journal:  Cells       Date:  2021-05-10       Impact factor: 6.600

10.  CD47 Expression in Natural Killer Cells Regulates Homeostasis and Modulates Immune Response to Lymphocytic Choriomeningitis Virus.

Authors:  Pulak Ranjan Nath; Arunakumar Gangaplara; Dipasmita Pal-Nath; Ajeet Mandal; Dragan Maric; John M Sipes; Maggie Cam; Ethan M Shevach; David D Roberts
Journal:  Front Immunol       Date:  2018-12-20       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.